WPA
Winning Points Advisors’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $143K | Buy |
+89,396
| New | +$143K | 0.24% | 29 |
|
|
2024
Q1 | $466K | Hold |
92,786
| – | – | 0.72% | 21 |
|
|
2023
Q4 | $466K | Buy |
92,786
+3,390
| +4% | +$17K | 0.72% | 21 |
|
|
2023
Q3 | $143K | Sell |
89,396
-3,390
| -4% | -$5.42K | 0.25% | 30 |
|
|
2023
Q2 | $466K | Sell |
92,786
-158,400
| -63% | -$795K | 0.72% | 21 |
|
|
2023
Q1 | $461K | Buy |
251,186
+8,600
| +4% | +$15.8K | 0.51% | 29 |
|
|
2022
Q4 | $1.23M | Sell |
242,586
-8,970
| -4% | -$45.4K | 1.56% | 14 |
|
|
2022
Q3 | $1.39M | Buy |
251,556
+14,600
| +6% | +$80.5K | 1.7% | 14 |
|
|
2022
Q2 | $879K | Buy |
236,956
+176,830
| +294% | +$656K | 0.97% | 23 |
|
|
2022
Q1 | $339K | Buy |
+60,126
| New | +$339K | 0.26% | 47 |
|
|
2021
Q4 | – | Sell |
-43,958
| Closed | -$428K | – | 73 |
|
|
2021
Q3 | $428K | Buy |
43,958
+2,483
| +6% | +$24.2K | 0.31% | 44 |
|
|
2021
Q2 | $593K | Buy |
41,475
+1,475
| +4% | +$21.1K | 0.44% | 40 |
|
|
2021
Q1 | $974K | Hold |
40,000
| – | – | 0.73% | 32 |
|
|
2020
Q4 | $533K | Buy |
+40,000
| New | +$533K | 0.43% | 39 |
|